Storia in 2 fonti

Heart failure drug from Tenax Therapeutics fails in pivotal study

A Tenax Therapeutics drug designed to treat a type of heart failure associated with high blood pressure in the lungs failed in a closely watched study.

Raccontata da

statnews.com

benzinga.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

statnews.comStai leggendo3 g fa

Heart failure drug from Tenax Therapeutics fails in pivotal study

A Tenax Therapeutics drug designed to treat a type of heart failure associated with high blood pressure in the lungs failed in a closely watched study.

originale

benzinga.com3 g fa

Tenax Therapeutics Stock Dives as It Faces Heart Drug Study Setback - Tenax Therapeutics (NASDAQ:TENX)

Tenax Therapeutics announced Phase 3 LEVEL trial results for TNX-103, missing primary endpoints while showing subgroup benefits.

Leggi questa versione → originale

Timeline cronologica

lunedì 10 agosto 2026·statnews.com
Heart failure drug from Tenax Therapeutics fails in pivotal study
A Tenax Therapeutics drug designed to treat a type of heart failure associated with high blood pressure in the lungs failed in a closely watched study.
lunedì 10 agosto 2026·benzinga.com
Tenax Therapeutics Stock Dives as It Faces Heart Drug Study Setback - Tenax Therapeutics (NASDAQ:TENX)
Tenax Therapeutics announced Phase 3 LEVEL trial results for TNX-103, missing primary endpoints while showing subgroup benefits.